Scout | NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) offers funding for high-risk, multi-center clinical studies through a two-part process. This includes the possibility of receiving a U34 planning grant. The U34 grant allows for early peer review and evaluation of the study's rationale, design, and protocol. It also provides resources for developing necessary study do…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Diabetes and Digestive and Kidney Diseases

Award

Award Ceiling: $225,000

Funding Amount: $225,000

Dates

Opportunity Released: January 4, 2024

Open for Submission: January 4, 2024

Submission Deadline: June 10, 2027

Application Window Closes: June 10, 2027

Keywords

NIDDK

investigator-initiated

high-risk

multi-center clinical studies

U34 grant

clinical study design

hypothesis-driven research

disease-focused

clinical study protocol

peer review

NIDDK mission diseases

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers